MLA medical australia limited

Ann: Appendix 4C - quarterly, page-2

  1. 1,046 Posts.
    lightbulb Created with Sketch. 40
    Immediate thoughts here... staff payments up (as per that comment in the SIA booklet) from circa 825k  (Mar-17) to 951k this quarter.


    "Employee benefit expenses is MLA's largest overhead, accounting for approximately 60-64% of overheads across the period reviewed. Employee benefits expenses have increased largely in line with sales growth, with employee expenses representing 24.1% , 24.2% and 24.5% of sales in FY 15A, FY16A and FY17A, respectively. Employee benefits expenses are budgeted to increase by $522k (16.2%) to $3.7m in FY18B, which represents 28.6% of budgeted sales. Management has advised that the increase relates to new staff hires associated with both the Tuta and Clements (including Ardo) divisions."


    And surprisingly quarterly revenue's largely unchanged at $3.22m  vs $3.18m Sep-16 quarter. In my view the headline cashflow reduction looks somewhat misleading, would be in line with the view that OEM revenue is on the decrease and significant gains in Ardo/Clements are continuing to offset as the sales team's experience and output gathers steam.


    Solid 3.2m bid @ 8.4c still there.


    all IMO, DYOR etc...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.